Skip to main content
Top
Published in: AIDS and Behavior 5/2023

07-11-2022 | Circumcision | Original Paper

The 1982 Medicaid Funding Cessation for Circumcision in California and Circumcision Rates

Authors: Rebecca Y Linfield, Ryan Wendling, David J.G. Slusky

Published in: AIDS and Behavior | Issue 5/2023

Login to get access

Abstract

We investigated California’s 1982 decision to stop funding Medicaid neonatal circumcision. We examined male neonatal circumcision rates for those born 1977–1981 and 1983–1987 by region, race, and insurance status. Overall, West-Medicaid circumcision rates decreased from 56.5% in 1979-81 to 26.7% in 1983-85. California’s 1982 decision to defund Medicaid circumcision coverage was associated with a 25.0-30.8% point decrease in West-Medicaid circumcision rates compared other groups, p < 0.01. This provides the earliest data to support that funding coverage for neonatal circumcision affects circumcision rates and magnifies healthcare disparities. Other states have since defunded Medicaid male neonatal circumcision. Circumcision have been associated with lower rates of sexually transmitted infections including HIV, and urinary tract infections. Lawmakers should consider re-funding Medicaid male neonatal circumcision.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schoen EJ, Colby CJ, To TT. Cost analysis of neonatal circumcision in a large health maintenance organization. The Journal of Urology. 2006 Mar 1;175(3):1111-5. Schoen EJ, Colby CJ, To TT. Cost analysis of neonatal circumcision in a large health maintenance organization. The Journal of Urology. 2006 Mar 1;175(3):1111-5.
2.
go back to reference Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005 Nov;2(11):e298.CrossRefPubMedPubMedCentral Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005 Nov;2(11):e298.CrossRefPubMedPubMedCentral
3.
go back to reference Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. The Lancet. 2007 Feb;24(9562):643–56.CrossRef Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. The Lancet. 2007 Feb;24(9562):643–56.CrossRef
4.
go back to reference Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. The Lancet. 2007 Feb;24(9562):657–66.CrossRef Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. The Lancet. 2007 Feb;24(9562):657–66.CrossRef
5.
go back to reference Gray RH, Kigozi G, Kong X, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a post-trial follow up study in Rakai, Uganda. AIDS (London, England). 2012 Mar 3;26(5):609. Gray RH, Kigozi G, Kong X, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a post-trial follow up study in Rakai, Uganda. AIDS (London, England). 2012 Mar 3;26(5):609.
6.
go back to reference Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. New England Journal of Medicine. 2009 Mar 26;360(13):1298–309. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. New England Journal of Medicine. 2009 Mar 26;360(13):1298–309.
7.
go back to reference Auvert B, Sobngwi-Tambekou J, Cutler E, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. The Journal of Infectious Diseases. 2009 Jan 1;199(1):14 – 9. Auvert B, Sobngwi-Tambekou J, Cutler E, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. The Journal of Infectious Diseases. 2009 Jan 1;199(1):14 – 9.
8.
go back to reference Centers for Disease Control and Prevention. HIV. surveillance report. 2018. Atlanta, GA: Centers for Disease Control and Prevention. 2020 May; 31. Centers for Disease Control and Prevention. HIV. surveillance report. 2018. Atlanta, GA: Centers for Disease Control and Prevention. 2020 May; 31.
10.
go back to reference Warner L, Ghanem KG, Newman DR, Macaluso M, Sullivan PS, Erbelding EJ. Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics. J Infect Dis. 2009 Jan;199(1)(1):59–65.CrossRefPubMed Warner L, Ghanem KG, Newman DR, Macaluso M, Sullivan PS, Erbelding EJ. Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics. J Infect Dis. 2009 Jan;199(1)(1):59–65.CrossRefPubMed
11.
go back to reference Kreiss JK, Hopkins SG. The association between circumcision status and human immunodeficiency virus infection among homosexual men. Journal of Infectious Diseases. 1993 Dec 1;168(6):1404-8. Kreiss JK, Hopkins SG. The association between circumcision status and human immunodeficiency virus infection among homosexual men. Journal of Infectious Diseases. 1993 Dec 1;168(6):1404-8.
12.
go back to reference Buchbinder SP, Vittinghoff E, Heagerty PJ, et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2005 May 1;39(1):82 – 9. Buchbinder SP, Vittinghoff E, Heagerty PJ, et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2005 May 1;39(1):82 – 9.
13.
go back to reference Wiswell TE, Enzenauer RW, Holton ME, Cornish JD, Hankins CT. Declining frequency of circumcision: implications for changes in the absolute incidence and male to female sex ratio of urinary tract infections in early infancy. Pediatrics. 1987 Mar;79(3):338–42.CrossRefPubMed Wiswell TE, Enzenauer RW, Holton ME, Cornish JD, Hankins CT. Declining frequency of circumcision: implications for changes in the absolute incidence and male to female sex ratio of urinary tract infections in early infancy. Pediatrics. 1987 Mar;79(3):338–42.CrossRefPubMed
14.
go back to reference Eisenberg ML, Galusha D, Kennedy WA, Cullen MR. The relationship between neonatal circumcision, urinary tract infection, and health. World J Men’s Health. 2018 Sep;36(3):176–82.CrossRef Eisenberg ML, Galusha D, Kennedy WA, Cullen MR. The relationship between neonatal circumcision, urinary tract infection, and health. World J Men’s Health. 2018 Sep;36(3):176–82.CrossRef
15.
go back to reference Larke NL, Thomas SL, dos Santos Silva I, Weiss HA. Male circumcision and penile cancer: a systematic review and meta-analysis. Cancer Causes & Control. 2011 Aug;22(8):1097–110.CrossRef Larke NL, Thomas SL, dos Santos Silva I, Weiss HA. Male circumcision and penile cancer: a systematic review and meta-analysis. Cancer Causes & Control. 2011 Aug;22(8):1097–110.CrossRef
17.
go back to reference Zambrano Navia M, Jacobson DL, Balmert LC, et al. State-level public insurance coverage and neonatal circumcision rates. Pediatrics. 2020 Nov 1;146(5). Zambrano Navia M, Jacobson DL, Balmert LC, et al. State-level public insurance coverage and neonatal circumcision rates. Pediatrics. 2020 Nov 1;146(5).
18.
go back to reference Leibowitz AA, Desmond K, Belin T. Determinants and policy implications of male circumcision in the United States. Am J Public Health. 2009 Jan;99(1):138–45.CrossRefPubMedPubMedCentral Leibowitz AA, Desmond K, Belin T. Determinants and policy implications of male circumcision in the United States. Am J Public Health. 2009 Jan;99(1):138–45.CrossRefPubMedPubMedCentral
20.
go back to reference Waskett JH. Hospital discharge data underestimate circumcision rates. Sexually Transmitted Diseases. 2007 Aug 1;34(8):624. Waskett JH. Hospital discharge data underestimate circumcision rates. Sexually Transmitted Diseases. 2007 Aug 1;34(8):624.
21.
go back to reference Xu F, Markowitz LE, Sternberg MR, Aral SO. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999–2004. Sex Transm Dis. 2007 Jul;1:479–84.CrossRef Xu F, Markowitz LE, Sternberg MR, Aral SO. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999–2004. Sex Transm Dis. 2007 Jul;1:479–84.CrossRef
22.
go back to reference Leibowitz AA, Desmond K. Infant male circumcision and future health disparities. Archives of pediatrics & adolescent medicine. 2012 Oct 1;166(10):962-3. Leibowitz AA, Desmond K. Infant male circumcision and future health disparities. Archives of pediatrics & adolescent medicine. 2012 Oct 1;166(10):962-3.
Metadata
Title
The 1982 Medicaid Funding Cessation for Circumcision in California and Circumcision Rates
Authors
Rebecca Y Linfield
Ryan Wendling
David J.G. Slusky
Publication date
07-11-2022
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2023
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-022-03896-y

Other articles of this Issue 5/2023

AIDS and Behavior 5/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine